Treatments, Device Technologies, and Global Markets, 2020-2021 and 2026

DublinAnd 25 April 2022 /PRNewswire/ – file Chronic disease management: treatments, device technologies, and global markets. Report added to ResearchAndMarkets.com an offer.

Research and Markets logo

Research and Markets logo

Chronic disease management includes many drugs and medical device-based technologies used to manage various chronic diseases. This report is an analytical business tool with the primary objective of providing a comprehensive assessment of the global market for chronic disease management through various therapies and advanced device technologies.

The report will provide a detailed exposure of the Chronic Disease Management Market. This report analyzes chronic disease management market trends with data from 2020, estimates from 2021, forecasts of compound annual growth rates to 2026 (forecast period 2021 – 2026), and chronic disease management regional markets.

This report will highlight the current and future market potential of Chronic Disease Management along with a detailed analysis of the competitive environment. The organizational scenario, drivers, limitations, and opportunities will be covered in the current report. The report also covers market forecast 2026, market shares of the major market players.

This report also deals with the analysis of the regional chronic disease management market. The market has been divided into different main areas including North AmaricaAnd EuropeAnd Asia Pacific, and the rest of the world. Detailed analysis of major countries such as the United States, GermanyUnited kingdom, ItaliaAnd FranceAnd JapanAnd ChinaAnd India It will be covered within the regional segment. For market estimations, data will be provided for 2020 as it is the base year, with estimates for 2021 and projected value for 2026.

The report includes:

  • An up-to-date review and analysis of the global market for chronic disease management therapies and device technologies

  • Analyzes of global market trends, with data from 2020, estimates for 2021, and forecasts for compound annual growth rates to 2026

  • Assessment and forecasting of overall market size and expected growth trends and corresponding market share analysis by product category, disease type, delivery technology, treatment adherence, treatment provider and region

  • Insights into the current state of chronic diseases and disorders, with emphasis on needle-free drug delivery technologies, diagnostic methods, and smart device technologies that support effective disease-state management

  • Pharmaceuticals and Medical Devices Organizational Structure, Pricing and Reimbursement Structure, Marketed Products and Pipelines, and Key Developments Affecting the Market

  • Major mergers and acquisitions, development of commercially viable products and technologies, and other strategic alliances within the industry

  • Profile descriptions of leading global companies including Abbott, AbbVie Inc, Amgen Inc, Bayer AG, Boston Scientific Corp., Dr. Reddy’s Laboratories Ltd, F Hoffman, GlaxoSmithKline plc, Johnson & Johnson, Medtronic, Novartis, Sanofi, Pfizer and Emphasis

Company Profile

  • Abbott

  • Abbvie Inc.

  • Acadia Pharmaceuticals

  • Accorda Treatments

  • Adherium

  • Agenus

  • Akron

  • Alefcore

  • kermes

  • Amgen Inc.

  • Amico

  • Amyl Pharmaceuticals

  • Life Sciences Anavex

  • Al-Ani Pharmaceuticals

  • botox

  • Arena Pharmaceuticals

  • Asahi Kasai Corporation.

  • Aslan Pharmaceuticals

  • Aspen Pharmacare

  • Astellas Pharma Company

  • AstraZeneca

  • Atherses

  • Axsome Treatments

  • Bausch Health Companies Inc.

  • Bayer AG

  • bikini

  • biology

  • vitality

  • Vitality

  • BIOTRONIC

  • BIOXELL TREATMENTS

  • Boehringer Ingelheim International GmbH

  • Boston Scientific Company

  • Bristol-Myers Squibb

  • BTS bioengineering

  • Chugai Pharmaceutical Co., Ltd.

  • Sibla

  • Clovis oncology

  • Connected Health Pte. Ltd.

  • Corpus Pharmaceuticals

  • Cspc pharmaceutical group

  • Daiichi Sankyo

  • labs

  • Early Sense

  • Edwards Lifesciences Corp.

  • Eli Lilly

  • empatica

  • Endo International

  • Endoceutics Inc.

  • Eritic Pharma

  • steve

  • Everest Health

  • F. Hoffmann-La Roche Ltd.

  • Gilead Sciences Corporation

  • GlaxoSmithKline Inc

  • Glooko Inc.

  • halozyme treatments

  • Wisdom Medicines

  • Hokuma

  • i health

  • Infobionic Corporation

  • Insulate Corp.

  • Intelsense

  • Intracellular therapies

  • Iovance Biotherapeutics

  • Ipsen SA

  • Jan Medical Company

  • Jiangsu Hengrui Medicine

  • Johnson & Johnson Services

  • Kiwa Haku Kirin

  • Server Labs

  • Lundbeck

  • lupine

  • Mallincrot plc

  • Medminder

  • Medtronic Corporation

  • Minarini

  • Merck Kja

  • Mitsubishi Tanabe Pharma

  • Nemaura Medical Inc.

  • Neofect Co., Ltd.

  • Neurobiological Sciences

  • Neurometrix Corporation

  • Novartis AG

  • Novo Nordisk

  • Nokana

  • Omada Health Inc.

  • Omnicell Inc.

  • Omron Corp.

  • Ono Pharmaceutical Co., Ltd.

  • Orion Pharma Ltd.

  • Otsuka Holdings Co. Ltd.

  • Pacira Pharmaceuticals Inc.

  • Pfizer Inc

  • Phylosis

  • Polar Electro Oy

  • Prescriboilness LLC

  • Preventice . company

  • fan health

  • Cardio

  • Rehab-Robotics (Member of Vincent Medical Holdings)

  • sage remedies

  • Sanofi SA

  • Sarepta Treatments

  • Sense4Care

  • Shanghai Pharmaceutical Holdings

  • Shionogi and Co. Ltd.

  • Stada Arzneimittel AG

  • Sumitomo Dainipon Pharma Co., Ltd.

  • Sun Pharmaceutical Industries

  • Taisho Pharmaceutical

  • Takeda Pharmaceutical Co., Ltd.

  • Therapeutics Tcr2

  • Teva Pharmaceutical Industries Ltd.

  • TIME Techniques

  • Vertex Pharmaceuticals

  • Viatris Corporation

  • vital communication

  • West Pharmaceutical Services Company

  • Winmedical Srl

  • Lipsomed Holding AG

  • Zogenix Company

  • Zydus Cadila

For more information about this report visit https://www.researchandmarkets.com/r/7cur39

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We bring you the latest data on international and regional markets, key industries, major companies, new products and the latest trends.

Media contact:

Research and Markets
Laura Wooddirector, mentor
press@researchandmarkets.com

For EST office hours, call +1-917-300-0470
For the US/Canada, call toll free +1-800-526-8630
For GMT office hours, call +353-1-416-8900

US Fax: 607-646-1904
Fax (outside the US): +353-1-481-1716

Cision

Cision

View original content:https://www.prnewswire.com/news-releases/chronic-disease-management-therapeutics-device-technologies-and-global-markets-2020-2021–2026-301531762.html

SOURCE Research & Markets